|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 37/00 | |
| A61K 31/20 | |||
| A61P 3/10 |
| (11) | Number of the document | 2180787 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08780348.2 |
| Date of filing the European patent application | 2008-08-01 | |
| (97) | Date of publication of the European application | 2010-05-05 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/009274 |
| Date | 2008-08-01 |
| (87) | Number | WO 2009/017802 |
| Date | 2009-02-05 |
| (30) | Number | Date | Country code |
| 953360 P | 2007-08-01 | US |
| (72) |
FREEMAN, Bruce, A., US
|
| (73) |
University of Pittsburgh - Of the Commonwealth System of Higher Education,
200 Gardner Steel Conference Center Thackeray & O`Hara Streets, Pittsburgh, PA 15260,
US
|
| (54) | NITRO OLEIC ACID MODULATION OF TYPE II DIABETES |
| NITRO OLEIC ACID MODULATION OF TYPE II DIABETES |